Status:
COMPLETED
S-1 and Photodynamic Therapy in Cholangiocarcinoma
Lead Sponsor:
Asan Medical Center
Conditions:
Cholangiocarcinoma
Eligibility:
All Genders
18-90 years
Phase:
PHASE3
Brief Summary
In patients with unresectable perihilar cholangiocarcinoma, photodynamic therapy with biliary stent has been known for palliation of jaundice and improving survival. But most of therapeutic effects we...
Detailed Description
In patients with unresectable perihilar cholangiocarcinoma, photodynamic therapy with biliary stent has been known for palliation of jaundice and improving survival. But most of therapeutic effects we...
Eligibility Criteria
Inclusion
- Histologic or cytologic diagnosis of cholangiocarcinoma
- Not eligible for curative surgery
- Eastern Cooperative Oncology Group (ECOG) performance status of 2 or better
- No serious or uncontrolled concomitant medical illness
- Adequate bone marrow function (absolute neutrophil count ≧1,500 ul, platelet count ≧75,000/ul)
- Consent this study in letter
Exclusion
- Another neoplasia
- Porphyria
- Pregnant or breastfeeding women
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT00869635
Start Date
February 1 2009
End Date
August 1 2013
Last Update
February 6 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, South Korea, 138-736